Michael Catelani - Apr 14, 2022 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
President
Signature
/s/ Michael J. Catelani
Stock symbol
ANIX
Transactions as of
Apr 14, 2022
Transactions value $
$0
Form type
4
Date filed
4/15/2022, 10:34 AM
Previous filing
Mar 11, 2022
Next filing
Apr 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +100K $0.00 100K Apr 14, 2022 Common Stock 100K $2.62 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning April 30, 2022.